What is the difference between Olympia Pharmacy pricing and pass-through pricing?

Olympia Pharmacy negotiates volume rates backed by 25+ years of 503A/503B buying power and delivers them through a clinical-liaison quote after a sales conversation. A pass-through model shows resolved per-vial 503A cost on each line before checkout with a separately disclosed fee.

When does a clinical-liaison quote model win?

When a clinic's volume in hormones, peptides, or liraglutide is high enough to extract aggressive negotiated rates from Olympia's buying power, and the buyer is comfortable committing before seeing per-vial cost. The upside is concentrated volume savings.

When does pass-through pricing win?

When a clinic needs to quote cash-pay patients on landed cost before the consult, wants to verify drug cost is not marked up, and values seeing cost on every SKU before ordering — regardless of volume level.

How do I compare the two models on my own numbers?

Get an itemized Olympia Pharmacy clinical-liaison quote on your top SKUs, read visible per-vial cost plus disclosed fee on the same SKUs, and normalize both to delivered per-vial cost including shipping over a representative month.

Which model fits most cash-pay clinics?

Clinics that must know per-vial cost before setting patient pricing tend to favor pass-through, since a clinical-liaison quote arriving after onboarding cannot inform pricing set during evaluation.

Can I prove which model is cheaper for me?

Yes. With visible pass-through cost you can build a representative cart, read the totals, and set them against your Olympia Pharmacy clinical-liaison quote on the SKUs you actually order to prove the difference.

Olympia Pharmacy pricing vs pass-through alternatives

Olympia Pharmacy quote pricing vs pass-through: which model fits a clinic?

Olympia Pharmacy uses a clinical-liaison quote model: volume-negotiated rates with no middleman markup, confirmed through a clinical onboarding conversation. Olympia is a 503A and 503B compounder in Orlando, FL with over 25 years of compounding expertise. A pass-through alternative shows resolved per-vial 503A cost on each line before checkout with a disclosed fee. The economic difference is timing and verifiability — a clinical-liaison quote can win on negotiated volume savings, while pass-through wins on cost visibility before you order and quote patients.

This page compares the two pricing economies head to head and explains which clinic profiles each model fits best.

Compare Fizy Health vs Olympia Pharmacy

Proudly Partnered With

Two pricing economies, compared

A clinical-liaison quote model and a pass-through model solve the same problem — getting compounded medications to a clinic at a competitive price — through opposite mechanics. Olympia Pharmacy negotiates volume rates across its 503A pharmacy and FDA-registered 503B outsourcing facility, then delivers them through a clinical-liaison quote. The strength is potential negotiated savings backed by 25+ years of buying power; the cost is that you cannot see or verify the per-vial number until after engaging sales. A pass-through model shows the 503A drug cost per vial on each line before checkout and names a separate facilitation fee. The strength is visibility and verifiability; the trade-off is that it relies on transparent per-line cost rather than a separately negotiated volume discount.

Where each model wins on economics

Clinical-liaison quote pricing can win when a clinic's volume is high enough to extract aggressive negotiated rates, and when the buyer is comfortable committing before seeing per-vial cost. Olympia's buying-power claim is substantiated by its 503A/503B dual capability and longevity in the compounding market — volume that justifies those rates earns real savings. The risk is that the rate is unverifiable up front and may pair with fees or minimums that change landed cost. Pass-through pricing wins when a clinic needs to quote cash-pay patients on landed cost before the consult, wants to verify that drug cost is not marked up, and values seeing the number on every SKU before ordering. Its limit is that it depends on the underlying 503A cost rather than a separately negotiated volume discount.

Most cash-pay clinics care most about one thing: knowing per-vial cost before they set patient pricing. That single requirement tends to favor a pass-through model, because a clinical-liaison quote that arrives after onboarding cannot inform pricing you need to set during evaluation. But a high-volume operation already comfortable with negotiated contracts — and whose formulary aligns with Olympia's hormone, peptide, and liraglutide strengths — may rationally prefer the quote path. The right answer depends on the clinic.

How to run the comparison on your own numbers

Do not decide on model labels; decide on landed cost for your real SKUs. Get an itemized Olympia Pharmacy quote that separates drug cost from any fees — shipping, processing, DrScript portal, minimums — on your top SKUs. Then open a pass-through catalog and read the visible per-vial cost plus disclosed facilitation fee on the same drug, strength, and vial size. Normalize both to delivered per-vial cost over a representative month.

With Fizy Health you can do half of that comparison immediately, because it shows resolved per-vial 503A cost on each catalog and cart line before checkout and discloses a single facilitation fee at payment. Build a representative cart, read the totals, and set that against your Olympia Pharmacy clinical-liaison quote. Whichever model delivers lower true landed cost on the SKUs you actually order is the right choice — and now you can prove it rather than assume it.

Clinical-liaison quote economics — or visible pass-through economics?

Olympia Pharmacy fits if